$ARES

Ares Management reported Q2 results meeting revenue expectations at $1.28B and modestly beating consensus adjusted EPS with $1.29 vs $1.27. Management cited strong fundraising, including a record $36B raised and about 17% YoY growth in AUM and fee-paying assets. Analyst questions covered private credit demand, M&A and private equity expansion, direct lending outlook, margin drivers, and interval fund liquidity.

Bloomberg reports that Ares Management (NYSE:ARES) is leading a $2.2 billion direct loan to fund pharmacy benefits manager MedImpact Holdings’ planned acquisition of Medical Card System in Puerto Rico. The deal is expected to price at least 8 percentage points over benchmark and be second-lien. ARES shares fell 2.3% Wednesday.

Blackstone reported that realized performance compensation (carried interest) paid to employees in its private credit and insurance segment fell 51% year-on-year in the first half. Johnson Associates forecasts private credit performance pay flat to down 10% in 2026, while investment bank DCM bonuses may rise 5% to 10%.

Spear’s 2026 rankings highlight advisers for private equity and other alternative assets for UHNW investors. It cites McKinsey’s claim of over $1 trillion in 2025 private equity deal value and notes major firms’ AUM. It also discusses private credit liquidity concerns after Blue Owl Capital ended quarterly redemptions and EQT’s £2.7 billion purchase of Coller Capital.

Bloomberg reports that Ares is in talks with Toscafund regarding financing Toscafund’s bid to acquire Spire Healthcare. The report links Ares, Toscafund, and Spire Healthcare in a potential acquisition arrangement, which could affect deal expectations and related trading in the involved companies.

Ares Management (ARES) reported Q2 2026 results on an earnings call. Total AUM was about $671B, up 17% year over year, with gross fundraising of $36B. Fee-related earnings were about $491M (+20%), realized income about $522M (+31%), and after-tax realized income $1.29 per share (+25%). The company declared a $1.35 dividend per share.

Ares Management shares rose 5.3% to $134.92 after its Q2 2026 results. The company reported revenue of $1.43B vs. $1.33B expected, after-tax realized income per share of $1.29 (+25% YoY), and record $36.4B gross fundraising, lifting AUM 17% to $671.3B. Analysts raised price targets following the beat.

Ares Management reported Q2 2026 fundraising of over $36 billion, bringing total assets under management to about $671 billion as of June 30. The firm said dry powder reached a record $170 billion, about 25% of AUM. Fee-related earnings were $491.1 million, GAAP net income $150.6 million, and it declared a $1.35 common dividend.

Ares Management (ARES) reported record Q2 2026 fundraising of about $36B, with AUM up 17% YoY to $671B and fee-paying AUM up to $410B. Deployment rose to $36B and forward pipeline improved 20% sequentially. Management expects 2026 to be another record year, with FRE margins nearing the upper end of its 0-150 bps guidance and plans new non-traded BDC share classes.

Ares Management reported record Q2 fundraising of $36 billion, led by its credit segment with $23.7 billion and real assets with $9.7 billion. AUM rose 17% to $671.3 billion and fee-related earnings increased 20% to $491.1 million. It deployed $35.9 billion and said uninvested capital rose 13% to $170 billion. After-tax realised income per share was $1.29.